药品名称CYTARABINE
申请号016793产品号004
活性成分CYTARABINE市场状态停止上市
剂型或给药途径INJECTABLE;INJECTION规格2GM/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期1987/12/21申请机构TEVA PARENTERAL MEDICINES INC
化学类型New molecular entity (NME)审评分类Priority review drug
与本品相关的专利信息(来自橙皮书Orange Book)
专利号专利过期日是否化合物专利是否产品专利专利用途代码专利下载
历史专利信息
与本品相关的市场独占权保护信息
独占权代码失效日期
历史市场独占权保护信息
与药品注册相关的信息
申请号修订号审批结论公开文档类型文档创建时间获取文档
药品注册审批历史信息
申请号修订号审批结论审批日期审批内容
016793060AP2000/04/03Control Supplement
016793059AP1998/10/15Labeling Revision
016793058AP1996/01/24Labeling Revision
016793057AP1995/11/01Manufacturing Change or Addition
016793056AP1995/06/14Labeling Revision
016793055AP1994/09/27Manufacturing Change or Addition
016793052AP1990/01/08Labeling Revision
016793051AP1987/12/21Labeling Revision
016793050AP1987/02/24Manufacturing Change or Addition
016793049AP1987/04/17Labeling Revision
016793047AP1987/12/21Package Change
016793046AP1986/07/28Expiration Date Change
016793041AP1983/10/21Labeling Revision
016793039AP1986/01/31Control Supplement
016793038AP1983/05/11Labeling Revision
016793037AP1982/12/30Labeling Revision
016793034AP1981/03/31Package Change
016793033AP1979/02/23Labeling Revision
016793032AP1979/10/29Labeling Revision
016793030AP1976/03/10Control Supplement
016793029AP1975/10/23Control Supplement
016793025AP1974/04/24Other Amendment
016793000AP1969/06/17Approval